Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity (Nature (2017) 551 (340-345) DOI: 10.1038/nature24302);Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity

Nature

Volumn 551, Issue 7680, 2017, Pages 340-345

  Shalapour, Shabnam ^a   Lin, Xue Jia ^a,b   Bastian, Ingmar N ^a   Brain, John ^c   Burt, Alastair D ^d   Aksenov, Alexander A ^e   Vrbanac, Alison F ^f   Li, Weihua ^a   Perkins, Andres ^a   Matsutani, Takaji ^g   Zhong, Zhenyu ^a   Dhar, Debanjan ^a   Navas Molina, Jose A ^f   Xu, Jun ^h   Loomba, Rohit ^h   Downes, Michael ⁱ   Yu, Ruth T ⁱ   Evans, Ronald M ⁱ   Dorrestein, Pieter C ^e,j   Knight, Rob ^f,j   Benner, Christopher ^h   Anstee, Quentin M ^c   Karin, Michael ^a,j   more..

^a University of California San Diego   (United States)

^b JINAN UNIVERSITY   (China)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Repertoire Genesis Incorporation   (Japan)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^j UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; INTERLEUKIN 10; PROGRAMMED DEATH 1 LIGAND 1; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; CD8 ANTIGEN; CD8 ANTIGEN, ALPHA CHAIN;

ANTIBODY; ANTIGEN; CANCER; CELLS AND CELL COMPONENTS; DEVELOPMENTAL BIOLOGY; DISEASE INCIDENCE; EMERGENCE; IMMUNITY; LIGAND; PROTEIN; REGRESSION ANALYSIS; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL LINE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; ANIMAL; CELL CLONE; CELL PROLIFERATION; COMPLICATION; CYTOLOGY; DEFICIENCY; DISEASE EXACERBATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFLAMMATION; INTESTINE FLORA; LIVER CIRRHOSIS; LIVER TUMOR; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PLASMA CELL;

MUS;

ANIMALS; B7-H1 ANTIGEN; CARCINOMA, HEPATOCELLULAR; CD8 ANTIGENS; CELL PROLIFERATION; CLONE CELLS; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN A; INFLAMMATION; INTERLEUKIN-10; LIVER CIRRHOSIS; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; PLASMA CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 85034443159     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature25028     Document Type: Erratum

References (76)

1. Sharma, P., Wagner, K., Wolchok, J. D. & Allison, J. P. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat. Rev. Cancer 11, 805-812 (2011).
2. Rosenberg, S. A. & Restifo, N. P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62-68 (2015).
3. Mittal, D., Gubin, M. M., Schreiber, R. D. & Smyth, M. J. New insights into cancer immunoediting and its three component phases - elimination, equilibrium and escape. Curr. Opin. Immunol. 27, 16-25 (2014).
4. Corthay, A. Does the immune system naturally protect against cancer? Front. Immunol. 5, 197 (2014).
5. Singal, A. G. & El-Serag, H. B. Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin. Gastroenterol. Hepatol. 13, 2140-2151 (2015).
6. Luedde, T. & Schwabe, R. F. NF-κ B in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 8, 108-118 (2011).
7. Wolf, M. J. et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26, 549-564 (2014).
8. Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P. & Chisari, F. V. Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188, 341-350 (1998).
9. Dhanda, A. D. & Collins, P. L. Immune dysfunction in acute alcoholic hepatitis. World J. Gastroenterol. 21, 11904-11913 (2015).
10. Baroni, G. S. et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 23, 1189-1199 (1996).
11. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Limón, P. The polarization of immune cells in the tumour environment by TGFβ. Nat. Rev. Immunol. 10, 554-567 (2010).
12. Mauri, C. & Menon, M. The expanding family of regulatory B cells. Int. Immunol. 27, 479-486 (2015).
13. McPherson, S., Henderson, E., Burt, A. D., Day, C. P. & Anstee, Q. M. Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease. J. Hepatol. 60, 1055-1062 (2014).
14. Shalapour, S. et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 521, 94-98 (2015).
15. Nakagawa, H. et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell 26, 331-343 (2014).
16. Font-Burgada, J. et al. Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162, 766-779 (2015).
17. Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208 (2010).
18. Malik, A. et al. IL-33 regulates the IgA-microbiota axis to restrain IL-1a-dependent colitis and tumorigenesis. J. Clin. Invest. 126, 4469-4481 (2016).
19. Cerutti, A. The regulation of IgA class switching. Nat. Rev. Immunol. 8, 421-434 (2008).
20. Schulze, K. et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 47, 505-511 (2015).
21. He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384-396 (2013).
22. Brandtzaeg, P. Secretory IgA: designed for anti-microbial defense. Front. Immunol. 4, 222 (2013).
23. Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504-516 (2012).
24. Seki, E. et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332 (2007).
25. Phan, T. G. et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197, 845-860 (2003).
26. Ma, C. et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531, 253-257 (2016).
27. Good-Jacobson, K. L. et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 11, 535-542 (2010).
28. Kim, P. S. & Ahmed, R. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22, 223-230 (2010).
29. Shalapour, S. & Karin, M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J. Clin. Invest. 125, 3347-3355 (2015).
30. Mellman, I. et al. De-risking immunotherapy: report of a consensus workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute. Cancer Immunol. Res. 4, 279-288 (2016).
31. Kang, T. W. et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551 (2011).
32. El-Khoueiry, A. B. et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet 389, 2492-2502 (2017).
33. Madan, R. et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312-2320 (2009).
34. Kitamura, D., Roes, J., Kühn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350, 423-426 (1991).
35. Harriman, G. R. et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 162, 2521-2529 (1999).
36. Koh, D. R. et al. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/-mice. Science 256, 1210-1213 (1992).
37. Mombaerts, P. et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
38. Chen, J. et al. Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus. Int. Immunol. 5, 647-656 (1993).
39. Silveira, P. A. et al. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32, 3657-3666 (2002).
40. Shimada, S. et al. Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J. Immunol. 163, 5367-5373 (1999).
41. Forrester, E. et al. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65, 2296-2302 (2005).
42. Phan, T. G., Gardam, S., Basten, A. & Brink, R. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J. Immunol. 174, 4567-4578 (2005).
43. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
44. Fujii, M. et al. A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med. Mol. Morphol. 46, 141-152 (2013).
45. Kleiner, D. E. & Makhlouf, H. R. Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin. Liver Dis. 20, 293-312 (2016).
46. He, G. et al. Hepatocyte IKKβ /NFκ B inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17, 286-297 (2010).
47. Meng, F., et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 143, 765-776 e761-763 (2012).
48. Yoshida, R. et al. A new method for quantitative analysis of the mouse T-cell receptor V region repertoires: comparison of repertoires among strains. Immunogenetics 52, 35-45 (2000).
49. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).
50. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
51. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
52. de Hoon, M. J., Imoto, S., Nolan, J. & Miyano, S. Open source clustering software. Bioinformatics 20, 1453-1454 (2004).
53. Saldanha, A. J. Java Treeview-extensible visualization of microarray data. Bioinformatics 20, 3246-3248 (2004).
54. Tripathi, S. et al. Meta-and orthogonal integration of influenza "OMICs" data defines a role for ubr4 in virus budding. Cell Host Microbe 18, 723-735 (2015).
55. Mootha, V. K. et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
56. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
57. Totoki, Y. et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 46, 1267-1273 (2014).
58. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
59. Van der Auwera, G.A., et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinform. 43, 11.10.1-33 (2013).
60. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
61. Keane, T. M. et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature 477, 289-294 (2011).
62. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80-92 (2012).
63. Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178-192 (2013).
64. Teufel, A., et al. Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients. Gastroenterology 151, 513-525 (2016).
65. Röst, H. L. et al. OpenMS: a flexible open-source software platform for mass spectrometry data analysis. Nat. Methods 13, 741-748 (2016).
66. Xia, J. & Wishart, D.S. Using MetaboAnalyst 3.0 for comprehensive metabolomics data analysis. Curr. Protoc. Bioinform. 55, 14.10.11-14.10.91 (2016).
67. Caporaso, J. G. et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 6, 1621-1624 (2012).
68. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335-336 (2010).
69. Ammon, A. et al. Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems 2, e00191-16 (2017).
70. Mirarab, S., Nguyen, N. & Warnow, T. SEPP: SATé-enabled phylogenetic placement. Pac. Symp. Biocomput. 17, 247-258 (2012).
71. McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610-618 (2012).
72. McDonald, D. et al. The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. Gigascience 1, 7 (2012).
73. Faith, D. P. Conservation evaluation and phylogenetic diversity. Biol. Conserv. 61, 1-10 (1992).
74. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71, 8228-8235 (2005).
75. Vázquez-Baeza, Y., Pirrung, M., Gonzalez, A. & Knight, R. EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience 2, 16 (2013).
76. Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663 (2015).